fashion -WSS

fashion

author：focus 2025-10-01 04:13:28 - browse：3

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： National associations that represent hospice owe an apology

focus

WSS

Emergent cuts jobs, executive role in business shake

Wegovy’s successful heart trial raises vital question about weight loss

How to make over

How to make over

Study: Spinal cord stimulation helps patients with paralysis walk again

Anavex keeps shifting the goalposts in its clinical trials

explore

fashion

knowledge

Cancer drug shortages should be causing more outrage

Maui's cultural, historic landmarks damaged in the devastating wildfires

Moonlake's readout produced a cash windfall. Risks remain

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

After affirmative action ruling, medical educators look to 'holistic review'

Wegovy improves function in certain heart failure patients

Apple is now the first public company to be valued at $3 trillion

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

New air purifier tech could be key to improving indoor air quality

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

knowledge

A biotech analyst on neuroscience, placebo effect, not over

Maui's cultural, historic landmarks damaged in the devastating wildfires

FDA greenlights medical device to combat bladder issues

Wegovy improves function in certain heart failure patients

Man killed during FBI raid in connection with threats against Biden, other officials

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

hotspot

focus

hotspot

focus